LMR Partners LLP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
LMR Partners LLP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$7,133,279
+358.7%
461,104
+365.8%
0.08%
+370.6%
Q2 2023$1,555,133
-34.5%
98,990
-34.6%
0.02%
-58.5%
Q4 2022$2,373,741
-69.0%
151,409
-74.3%
0.04%
-70.9%
Q3 2022$7,658,000
+10.6%
588,614
+15.9%
0.14%
+98.6%
Q4 2021$6,922,000
+31.8%
507,814
+60.7%
0.07%
+20.3%
Q3 2021$5,253,000
-62.3%
316,014
-62.1%
0.06%
-72.0%
Q2 2021$13,948,000
+336.4%
833,456
+374.5%
0.21%
+163.8%
Q1 2021$3,196,000
-92.6%
175,644
-92.8%
0.08%
-91.0%
Q3 2020$43,425,000
-27.3%
2,446,614
-27.0%
0.89%
-39.9%
Q2 2020$59,728,000
+11.8%
3,351,142
-2.7%
1.49%
-40.3%
Q1 2020$53,408,000
+56.1%
3,443,985
+100.7%
2.49%
+4350.0%
Q4 2019$34,221,000
-21.0%
1,716,402
-32.3%
0.06%
-97.4%
Q3 2019$43,306,000
-46.5%
2,536,884
-44.4%
2.14%
-27.3%
Q2 2019$80,884,000
+184.9%
4,563,591
+227.8%
2.95%
+103.5%
Q1 2019$28,391,0001,392,3351.45%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders